Bile acid cytoprotection mechanisms in hepatocytes

Bile acids/salts have detergent properties that can disrupt hepatocyte membranes and trigger injury; their cytotoxicity depends on bile acid species and concentration as well as the lipid milieu in bile and hepatocyte membranes[1][2]. Hepatocytes employ multiple cytoprotective mechanisms, including the coordinated secretion of phosphatidylcholine (via ABCB4) and cholesterol (via ABCG5/ABCG8) into bile, where mixed micelles reduce free monomeric bile salts; reduced biliary phospholipids heighten bile salt cytotoxicity and contribute to cholestatic disease[1]. Phosphatidylcholine is cytoprotective against diverse bile salts, whereas cholesterol can counteract this protection by shifting bile salt–lipid equilibria toward simple micelles/monomers that are more cytotoxic[2]. Beyond biophysical protection, hepatocytes activate signaling programs in response to toxic bile acids: they upregulate inflammatory mediators (e.g., CCL2, CXCL2, ICAM-1) in an EGR1-dependent manner, which recruits neutrophils and other immune cells; evidence indicates that neutrophil-driven oxidative injury is a key effector of cholestatic hepatocyte death[3][4]. Historically, glycochenodeoxycholic acid (GCDCA) has been used to model bile acid–induced apoptosis in hepatocytes, while UDCA exhibits protective effects in this context[5]. Collectively, “bile acid cytoprotection mechanisms” encompass membrane lipid–based protection in bile, transporter-mediated bile formation, and intracellular stress/inflammatory responses that modulate survival versus injury in hepatocytes[1][2][3][4][5].

Cytoprotective bile acids (e.g., UDCA/TUDCA) reduce bile acid–induced injury and inflammatory signaling in hepatocytes[5][4].